The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 24, 2021
Filed:
Nov. 19, 2018
Applicant:
Celgene Car Llc, Pembroke, BM;
Inventors:
Matthew David Alexander, San Diego, CA (US);
Joseph John McDonald, Sudbury, MA (US);
Yike Ni, Lexington, MA (US);
Deqiang Niu, Lexington, MA (US);
Russell C. Petter, Stow, MA (US);
Lixin Qiao, Andover, MA (US);
Juswinder Singh, Southborough, MA (US);
Tao Wang, Sudbury, MA (US);
Zhendong Zhu, Westborough, MA (US);
Assignee:
Celgene CAR LLC, Pembroke, BM;
Primary Examiner:
Int. Cl.
CPC ...
C07D 487/04 (2006.01); C07D 519/00 (2006.01); C07D 213/74 (2006.01); C07D 213/75 (2006.01); C07D 401/04 (2006.01); C07D 401/12 (2006.01); C07D 413/04 (2006.01); C07D 413/12 (2006.01); C07D 471/04 (2006.01); C07D 471/14 (2006.01); C07D 471/20 (2006.01); C07D 487/10 (2006.01); C07D 495/04 (2006.01); C07D 495/14 (2006.01); A61K 47/64 (2017.01); C12N 9/12 (2006.01); C12N 9/96 (2006.01); C12N 9/99 (2006.01); G01N 33/573 (2006.01);
U.S. Cl.
CPC ...
C07D 519/00 (2013.01); A61K 47/64 (2017.08); C07D 213/74 (2013.01); C07D 213/75 (2013.01); C07D 401/04 (2013.01); C07D 401/12 (2013.01); C07D 413/04 (2013.01); C07D 413/12 (2013.01); C07D 471/04 (2013.01); C07D 471/14 (2013.01); C07D 471/20 (2013.01); C07D 487/04 (2013.01); C07D 487/10 (2013.01); C07D 495/04 (2013.01); C07D 495/14 (2013.01); C12N 9/12 (2013.01); C12N 9/96 (2013.01); C12N 9/99 (2013.01); G01N 33/573 (2013.01); C12Y 207/11001 (2013.01); G01N 2333/91205 (2013.01); G01N 2458/00 (2013.01); G01N 2500/04 (2013.01); G01N 2500/20 (2013.01);
Abstract
The present invention provides compounds of formula V: or pharmaceutically acceptable salts thereof, useful as inhibitors of MK2 kinases, compositions thereof, and methods of using the same.